Latest filing published 06 Aug 2026 for KESTRA MEDICAL TECHNOLOGIES, LTD., €131k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Filings by Alfred J. Ford Jr. span 2 companies, the busiest being Kestra Medical Technologies, Ltd. and Axonics, Inc. We count 15 filings; the first trade dates from 31 January 2022 and the latest from 4 August 2026.
On the open market, the record shows 1 purchase worth €315k and 6 sales worth €1.6M. On balance, insiders were net sellers of €1.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 5 share grants and 2 option exercises. Since January 2026: no purchases and 4 sales on the market.
On 6 August 2026 came the latest disclosure, an open-market sale for €131k in Kestra Medical Technologies, Ltd. The latest purchase dates back some time: it was published 398 days ago, on 15 September 2025. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations